|
HS Code |
699731 |
| Chemical Name | 6-Bromopyridine-3-carboxylate |
| Molecular Formula | C6H4BrNO2 |
| Molar Mass | 202.01 g/mol |
| Cas Number | 85068-36-0 |
| Appearance | White to off-white solid |
| Melting Point | 90-94°C |
| Solubility In Water | Slightly soluble |
| Smiles | C1=CC(=NC=C1Br)C(=O)O |
| Inchi | InChI=1S/C6H4BrNO2/c7-5-2-1-4(6(9)10)3-8-5/h1-3H,(H,9,10) |
| Synonyms | 6-Bromo-3-pyridinecarboxylic acid |
| Storage Conditions | Store in a cool, dry place, tightly closed |
As an accredited 6-bromopyridine-3-carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 5 grams of 6-bromopyridine-3-carboxylate, labeled with chemical name, purity, and safety warnings. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL) for 6-bromopyridine-3-carboxylate ensures secure, efficient bulk packaging, protecting chemical integrity during international shipments. |
| Shipping | 6-Bromopyridine-3-carboxylate is shipped in tightly sealed containers to prevent moisture and contamination. It is packaged according to hazardous material regulations, with labeling compliant with international transport guidelines. The chemical is transported at ambient temperature, protected from light, and handled by trained personnel using appropriate safety measures to ensure safe and secure delivery. |
| Storage | **6-Bromopyridine-3-carboxylate** should be stored in a tightly sealed container, in a cool, dry, well-ventilated area away from incompatible substances such as strong oxidizing agents. Protect the chemical from moisture and light. Store at room temperature (typically 20–25 °C) and ensure proper labeling. Follow all local regulations and laboratory safety protocols for safe chemical storage. |
| Shelf Life | 6-Bromopyridine-3-carboxylate typically has a shelf life of 2-3 years when stored in a cool, dry, and dark place. |
|
Purity 98%: 6-bromopyridine-3-carboxylate with purity 98% is used in pharmaceutical intermediate synthesis, where it ensures high reaction efficiency and minimal byproduct formation. Melting Point 170°C: 6-bromopyridine-3-carboxylate with melting point 170°C is used in organic semiconductor preparation, where it provides thermal stability during device fabrication. Molecular Weight 216.01 g/mol: 6-bromopyridine-3-carboxylate with molecular weight 216.01 g/mol is used in agrochemical research, where it allows precise stoichiometric calculations for formulation. Solubility in DMSO: 6-bromopyridine-3-carboxylate with high solubility in DMSO is used in medicinal chemistry screening assays, where it facilitates uniform compound distribution. Light Sensitivity: 6-bromopyridine-3-carboxylate with low light sensitivity is used in fine chemical synthesis workflows, where it reduces the risk of degradation during handling. Particle Size ≤25 µm: 6-bromopyridine-3-carboxylate with particle size ≤25 µm is used in catalyst development, where it improves reaction kinetics and product homogeneity. Storage Temperature 2–8°C: 6-bromopyridine-3-carboxylate with recommended storage temperature 2–8°C is used in chemical inventory management, where it maintains product stability over extended periods. Assay (HPLC) ≥98%: 6-bromopyridine-3-carboxylate with HPLC assay ≥98% is used in active pharmaceutical ingredient design, where it enhances target specificity and minimizes impurities. |
Competitive 6-bromopyridine-3-carboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Sometimes, it’s easy to overlook a compound like 6-bromopyridine-3-carboxylate. In the sea of pyridine derivatives, each tweak to the structure can open a new door in synthesis, but with this particular compound, one can’t help reflecting on the shift it has spurred in research settings. As someone who spent a good amount of time evaluating building blocks for medicinal chemistry projects and watched countless candidate molecules rise and fall, there’s a certain respect owed to a molecule that actually solves problems others stumble over. The addition of a bromine atom at the sixth position of the pyridine ring with a carboxylate group snugged at the third may look like nothing spectacular at first glance. But the combination says a lot about where research is headed and how efficiency in the lab now matters more than ever.
It's easy to get hung up on tradition in chemistry. Old favorites like pyridine aren’t going away: they show up everywhere from classic textbooks to patents on new drugs. I’ve watched countless postdocs and industry chemists grab for standard halopyridines—often with a sigh—knowing the isolation, purification, or downstream reactivity can be a pain. The real benefit with 6-bromopyridine-3-carboxylate sneaks up on you after a few runs on the bench.
With a bromine at the six-position, the molecule sits ready for couplings that just don’t work as smoothly with chlorides, and especially not with iodides, which tend to be expensive and have their own quirks. That’s a big deal in Suzuki or Buchwald–Hartwig cross-couplings—not glamorous, but the kind of bread-and-butter work that drives both drug synthesis and material science. I remember the first time I swapped in a bromo-derivative for routine coupling. It cut down the stubborn side-products and cut my purification headaches in half. That’s real value—fewer wasted evenings at the column means more hours spent trying something new, or just getting home on time for once.
To really appreciate the edge 6-bromopyridine-3-carboxylate delivers, it’s worth putting aside the brochure’s list of melting points and purity claims. Anyone can Google the formula. What stood out for me came from actually watching colleagues struggle with similar compounds. Some pyridine carboxylates resist functionalization; some just never react the way theory predicts. 6-bromopyridine-3-carboxylate responds well to both palladium and copper catalysis, tolerates the solvents we’re already stocked with, and doesn't serve up surprise byproducts. It works in gram scales without ramping up cost or complexity—no jokes about price lists are needed here, but research budgets are constantly squeezed, so every extra run I got out of a bottle counted.
On the analytical front, the compound’s NMR and MS signals are clear and unambiguous. This means time saved from guesswork, faster handoffs between team members, and less reliance on secondary confirmatory tests—all things that keep projects moving without the kind of hidden delays that kill momentum in small teams. I’ve pulled plenty of late nights pushing new analogs, and cleaning up unclear spectra is not what anyone wants to spend their time on.
Having handled a fair lineup of pyridine-based intermediates, the subtle differences in reactivity matter a lot more than catalog descriptions let on. Some folks swear by 3-chloropyridine derivatives as cheap alternatives. They’re not wrong on price, but they overlook the sluggishness in couplings and the exasperation that the halide exchange brings later. Then there are iodide variants—highly reactive, but prone to instability, higher cost, and often not compatible with wider process parameters. The bromo position, especially at the sixth position, strikes a compromise between reactivity and practicality.
The carboxylate handle at the third position allows chemists to directly access esters, acids, or amide derivatives. In those situations, the position of the carboxylate actually influences not just how the molecule reacts, but how it interacts in biological systems. In my experience screening enzyme inhibitors, subtle structural shifts meant the difference between a promising IC50 and another dead end. By choosing 6-bromopyridine-3-carboxylate, teams can whip up a wider variety of biologically relevant structures without doubling the cost on custom synthesis or burning weeks repeating failed reactions.
Over the past decade, I’ve watched the shift in drug discovery from broad, random screens to more focused, structure-based projects. A compound like 6-bromopyridine-3-carboxylate isn’t a headliner but shows up again and again in the supporting cast. Medicinal chemists leverage it for developing kinase inhibitors or as an anchor for neurological disorder candidates. Material scientists have picked it up for functional materials—especially when precise, controlled substitution is essential for tuning the final product’s properties. Polymer chemists find the bromine allows for controlled, living polymerizations, something that isn’t as reliable with other functional groups.
On one project, a colleague in academic research used this compound to create new ligands tailored to specific metal catalysts. She cut down three weeks of trial-and-error steps simply by starting with a ready-activated bromo construct. In another case, process chemists scaled up a synthesis route for a contract pharma project. Picking 6-bromopyridine-3-carboxylate gave them a smoother path to their final intermediate, saving on both solvents and time, two things in short supply no matter the group’s size.
There’s a sweet spot between scarcity and shelf overload. While some pyridine derivatives make the rounds as “on paper” solutions, only a handful are widely available in trusted supply chains and consistent from batch to batch. In my years chasing down specialty chemicals, nothing wastes time and energy quite like an unpredictable supply. 6-Bromopyridine-3-carboxylate shows up on multiple suppliers’ lists, but the difference comes in reliability of supply, purity, and lot-to-lot performance. Teams with tight project timelines need consistency. The alternative too often involves lab-scale testing to confirm each shipment all over again—which, in the world of quarterly deliverables, is a gamble.
Inflated claims often surround the “next great building block”; rarely do these promises pan out. The best approach comes from hands-on experience. Most synthetic groups chase novelty, but, ironically, crave predictability in their tools. 6-Bromopyridine-3-carboxylate has earned its respect not through marketing but by standing up to repeated, rigorous use. In hit-to-lead campaigns, small shifts to the core structure can rescue abandoned projects. Medicinal chemists have leveraged this compound’s bromo and carboxylate combination to flash through analog libraries in days instead of weeks. I remember a case where the switch from a less functionalized pyridine to the 6-bromo, 3-carboxylate series cut down our synthetic sequence, letting us deliver over a dozen analogs for parallel activity screens a full two weeks ahead of schedule.
That kind of speedup isn’t about flash. It’s about doing more with the same bench space and headcount—making it possible to chase more leads and troubleshoot fewer unpredictable reactions. This, in the end, provides a competitive advantage that no new piece of lab equipment can substitute for.
Pyridine derivatives, including 6-bromopyridine-3-carboxylate, must be handled with care. The bromine atom brings with it all the practical concerns that halogenated aromatics deserve: gloves, good ventilation, and a sharp eye for waste handling protocols. One of the strengths of this compound is its manageable reactivity. While it must be treated with care—no one wants an avoidable spill or exposure—there aren’t the volatility or acute toxicity concerns of some analogous iodinated substances.
My experience taught me to never let the routine nature of a building block lull a team into complacency. Even familiar chemicals can turn on you if handled recklessly. Teams that maintain tight standard operating procedures and double-check MSDS recommendations tend to avoid the kind of small accidents that, over time, erode group morale and safety records. Fortunately, 6-bromopyridine-3-carboxylate falls into the category of manageable rather than precarious, but only if respect for the chemical persists.
Pricing in specialty chemicals always runs a little opaque. With research compounds, regular users crave a balance between price, purity, and packaging. I’ve sat in too many meetings explaining why the “cheaper” alternative wasn’t a bargain after factoring in failed reactions, slow deliveries, or contamination episodes. With 6-bromopyridine-3-carboxylate, upfront cost always looks a notch higher than generic pyridine-3-carboxylate. The economics flip on their head once you factor in improved yields and time saved from fewer purifications. For process-scale teams, avoiding bottlenecks is worth more than a few dollars saved per gram.
Bulk orders need planning—solid suppliers can usually ramp up without delay, but don’t count on just-in-time thinking to cover last-minute rushes. Many contract manufacturers and research outfits set up blanket orders or staggered deliveries to account for demand spikes. Anyone building a multi-step synthesis pipeline around 6-bromopyridine-3-carboxylate benefits from a little advanced planning on sourcing, but the cost is balanced by less wasted effort downstream.
Pressure grows every year to limit waste and environmental risk from chemical research and manufacturing. Pyridine-based compounds often generate halogenated side streams—costly to treat and dispose of responsibly. In many cases, using a more reactive and predictable starting material lowers the waste profile by increasing selectivity and reducing the number of purification steps. That’s true with 6-bromopyridine-3-carboxylate.
In collaborations with green chemistry teams, introducing this compound into reaction schemes often shifted the balance toward accepted green metrics: less solvent, fewer byproducts, and efficient atom economy. The improved selectivity meant that columns ran faster and wastes carried less unreacted starting material or rogue side-products. Some of the more forward-thinking labs tracked these metrics closely and found that this choice, minor as it seemed, could move reported E-factors enough to justify its regular inclusion on approved starting material lists.
Not every reagent offers a teachable moment, but 6-bromopyridine-3-carboxylate makes a strong case both in graduate classrooms and industry training. In workshops, this compound gives young chemists direct exposure to aryl halide couplings and rational substitution strategies. I watched new graduate students surprise themselves by outperforming “model reactions” with less reliable chlorides, thanks to the reliable activation the bromo position brings.
In professional research settings, training sessions often feature this compound as part of new method development for palladium catalysis. It shows up in challenge problems, where consistent reactivity serves as a benchmark for new catalysts—something highly valued by teams looking to validate processes before scaling them up. It’s practical in day-to-day use and a good teaching tool alike, reinforcing careful planning and smart use of structural features.
While it's common to default to the nearest available halogenated intermediate, direct experience says not all are created equal. Chlorides tend to resist oxidative addition, making catalysis slow and unreliable. Iodides provide higher reactivity, but are expensive, less stable, and not as widely stocked. Fluorinated derivatives sometimes attract attention for particular biological targets but are notorious for both price and unpredictability in challenging couplings.
The bromo substituent at the sixth position—especially married to the carboxylate at the third—strikes a balance that pays off day-to-day. It brings coupling speeds close to iodide without the same batch instability, all while remaining affordable and available from real suppliers. The product manages to support both small-scale medicinal chemistry sprints and the kind of process runs pharma contractors now demand.
As someone who has sat through countless compound selection meetings, I know the temptation to reach for the latest niche reagent in the hope of a synthetic shortcut. Most times, it doesn’t work out. But a few fundamental, flexible building blocks like 6-bromopyridine-3-carboxylate stay relevant year after year for a reason—they bridge gaps between core reactions, keep budgets in check, and let new concepts get off the ground faster.
Nowadays, teams can’t afford to pour resources into routes that turn unpredictable or fish for obscure derivatives that tie up budgets and time. Good foundational reagents, like this one, not only support new research but also allow teams to respond quicker to fresh data, adjust SAR plans, and pivot toward new targets in the middle of a campaign.
If there’s a lesson to share with younger chemists or procurement leads, it’s to value practical experience alongside catalog data. Over the long arc of a research program, it’s the building blocks with proven reliability that deliver the most innovative results. 6-Bromopyridine-3-carboxylate won its place not with flash or marketing, but by providing the kind of steady, flexible performance that research—basic or applied—actually depends on. The difference shows up not only in finished products and publications but in the day-to-day experience of those who spend their working lives at the bench.